All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Circle Pharma, Inc., a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable ...

AstraZeneca's Imfinzi was used before and after surgery in a clinical trial of patients with muscle-invasive bladder cancer — ...

including the departure of longtime CEO Jean-Jacques Bienaimé — replaced by former Genentech CEO Alexander Hardy — pressure from an activist investor to cut costs and doubts about some of the ...

Leland most recently served as the interim CEO and board director of ForeBio ... revenues related to a platform license provided to Genentech, a subsidiary of Swiss drug giant Roche RHHBY.

Opens in a new tab or window The former CEO of Liveyon -- the stem cell company ... In 2016, Kosolcharoen created Genetech (not to be confused with Genentech) and Liveyon to manufacture and ...

She will report to Teresa Graham, CEO of Roche Pharma, and become a member of the group’s pharma leadership team. “Ashley is a Roche and Genentech veteran, with a 20-year career that spans the ...

SAN FRANCISCO, Sept. 16, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the ...

Find out all you need to know about bispecific antibodies, including how they work and what the current clinical landscape ...

The new members are senior executives from the global leading pharmaceutical, biotech and technology industries and bring ...